A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery
This study has been completed.
Study NCT00644176
Information provided by Pfizer
First Received: March 19, 2008
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
